MARKET WRAP: JSE firms on vaccine news, while Shoprite drops on lockdown sales data
Moderna says its preliminary phase 3 trial data shows its Covid-19 vaccine is more than 94% effective
BL PREMIUM
16 November 2020 – 18:26
The JSE tracked firmer global markets on Monday after another Covid-19 vaccine developer reported encouraging results from its trials, while Shoprite lost the most on the day.
American biotechnology group Moderna said on Monday that its preliminary phase 3 trial data showed its Covid-19 vaccine was more than 94% effective — a result CEO Stephane Bancel called a “game changer”.
Source: businesslive.co.za
